CorMedix Inc. (CRMD): Operating Cash Flow
$175.05M
Year ended 2025-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $175.05M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$50.62M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$38.41M | n/m | 2025-03-25, From 2023-01-01 |
| 2022-12-31 | -$24.36M | n/m | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | -$21.16M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$21.97M | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$15.05M | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$23.70M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$28.59M | n/m | 2019-05-29, From 2017-01-01 |
| 2016-12-31 | -$22.27M | n/m | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | -$12.53M | n/m | 2017-03-16, From 2015-01-01 |
| 2014-12-31 | -$6.32M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$3.62M | n/m | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | -$2.28M | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$6.30M | n/m | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | -$3.67M | n/a | 2012-04-26, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| CorMedix Inc. (CRMD) | 2025-12-31 | $175.05M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$42.27M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $127.04M | +22.7% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $28.63M | n/m |
| MannKind Corp (MNKD) | 2025-12-31 | $18.25M | -57.1% |
| Harrow, Inc. (HROW) | 2025-12-31 | $43.86M | n/m |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $3.71M | n/m |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $49.36M | -49.1% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | -$273.80M | n/m |
Compare CRMD, EOLS, IRWD, XERS side by side · Screen every company in Pharmaceutical Preparations ↗